295 related articles for article (PubMed ID: 18039551)
41. Transplantation of unrelated donor umbilical cord blood utilizing double-unit grafts for five teenagers with transfusion-dependent thalassemia.
Jaing TH; Yang CP; Hung IJ; Chen SH; Sun CF; Chow R
Bone Marrow Transplant; 2007 Aug; 40(4):307-11. PubMed ID: 17572710
[TBL] [Abstract][Full Text] [Related]
42. FISH detection of chimerism in pediatric hematopoietic stem cell transplantation.
Aydin F; Oguz F; Onal AE; Bilgen H; Oguz R; Anak S; Carin M; Gedikoglu G
Int J Lab Hematol; 2007 Jun; 29(3):208-14. PubMed ID: 17474899
[TBL] [Abstract][Full Text] [Related]
43. Matched sibling donor hematopoietic stem cell transplantation for thalassemia.
Issaragrisil S; Kunacheewa C
Curr Opin Hematol; 2016 Nov; 23(6):508-514. PubMed ID: 27518930
[TBL] [Abstract][Full Text] [Related]
44. Searching for alternative hematopoietic stem cell donors for pediatric patients.
Rocha V; Locatelli F
Bone Marrow Transplant; 2008 Jan; 41(2):207-14. PubMed ID: 18084331
[TBL] [Abstract][Full Text] [Related]
45. BK-viruria and haemorrhagic cystitis are more frequent in allogeneic haematopoietic stem cell transplant patients receiving full conditioning and unrelated-HLA-mismatched grafts.
Giraud G; Priftakis P; Bogdanovic G; Remberger M; Dubrulle M; Hau A; Gutmark R; Mattson J; Svahn BM; Ringden O; Winiarski J; Ljungman P; Dalianis T
Bone Marrow Transplant; 2008 Apr; 41(8):737-42. PubMed ID: 18176615
[TBL] [Abstract][Full Text] [Related]
46. Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications.
Majhail NS; Mothukuri JM; Brunstein CG; Weisdorf DJ
Biol Blood Marrow Transplant; 2009 May; 15(5):564-73. PubMed ID: 19361748
[TBL] [Abstract][Full Text] [Related]
47. Indications and donor selections for allogeneic stem cell transplantation in children with hematologic malignancies.
Handgretinger R; Kurtzberg J; Egeler RM
Pediatr Clin North Am; 2008 Feb; 55(1):71-96, x. PubMed ID: 18242316
[TBL] [Abstract][Full Text] [Related]
48. A comparison between low intensity and reduced intensity conditioning in allogeneic hematopoietic stem cell transplantation for solid tumors.
Conrad R; Remberger M; Cederlund K; Ringdén O; Barkholt L
Haematologica; 2008 Feb; 93(2):265-72. PubMed ID: 18245651
[TBL] [Abstract][Full Text] [Related]
49. Fludarabine/i.v. BU conditioning regimen: myeloablative, reduced intensity or both?
Chunduri S; Dobogai LC; Peace D; Saunthararajah Y; Quigley J; Chen YH; Mahmud N; Hurter E; Beri R; Rondelli D
Bone Marrow Transplant; 2008 Jun; 41(11):935-40. PubMed ID: 18264144
[TBL] [Abstract][Full Text] [Related]
50. The harvest and use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation.
Stelljes M; van Biezen A; Slavin S; Olavarria E; Clark RE; Nagler A; Koza V; Kienast J; Niederwieser D; de Witte T; Ruutu T;
Bone Marrow Transplant; 2008 Dec; 42(11):739-42. PubMed ID: 18724394
[TBL] [Abstract][Full Text] [Related]
51. Gene therapy for homozygous beta-thalassemia. Is it a reality?
Boulad F; Rivière I; Sadelain M
Hemoglobin; 2009; 33 Suppl 1():S188-96. PubMed ID: 20001625
[TBL] [Abstract][Full Text] [Related]
52. Early identification and management of graft failure after unrelated cord blood transplantation.
Chan KW; Grimley MS; Taylor C; Wall DA
Bone Marrow Transplant; 2008 Jul; 42(1):35-41. PubMed ID: 18332909
[TBL] [Abstract][Full Text] [Related]
53. Hematopoietic stem cell transplantation after reduced intensity conditioning in acute myelogenous leukemia patients older than 40 years.
Huisman C; Meijer E; Petersen EJ; Lokhorst HM; Verdonck LF
Biol Blood Marrow Transplant; 2008 Feb; 14(2):181-6. PubMed ID: 18215778
[TBL] [Abstract][Full Text] [Related]
54. Increasing mixed chimerism and the risk of graft loss in children undergoing allogeneic hematopoietic stem cell transplantation for non-malignant disorders.
Ozyurek E; Cowan MJ; Koerper MA; Baxter-Lowe LA; Dvorak CC; Horn BN
Bone Marrow Transplant; 2008 Jul; 42(2):83-91. PubMed ID: 18391990
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of the pretransplantation phase of the hemopoietic stem cell program in a tertiary hospital.
Márquez Malaver FJ; Espigado Tocino I; Balsalobre López P; Carmona González M; Parody Ruiz-Berdejo R; Perez-Hurtado de Mendoza JM; Urbano Ispizua A
Transplant Proc; 2008 Nov; 40(9):3099-101. PubMed ID: 19010206
[TBL] [Abstract][Full Text] [Related]
56. Allogeneic/Matched Related Transplantation for β-Thalassemia and Sickle Cell Anemia.
Bernaudin F; Pondarré C; Galambrun C; Thuret I
Adv Exp Med Biol; 2017; 1013():89-122. PubMed ID: 29127678
[TBL] [Abstract][Full Text] [Related]
57. Second hematopoietic SCT in patients with thalassemia recurrence following rejection of the first graft.
Gaziev J; Sodani P; Lucarelli G; Polchi P; Marktel S; Paciaroni K; Marziali M; Isgrò A; Simone MD; Roveda A; Montuoro A; Lanti A; Alfieri C; De Angelis G; Gallucci C; Ciceri F; Roncarolo MG
Bone Marrow Transplant; 2008 Sep; 42(6):397-404. PubMed ID: 18574445
[TBL] [Abstract][Full Text] [Related]
58. Comparison of two doses of antithymocyte globulin in patients undergoing matched unrelated donor allogeneic stem cell transplantation.
Ayuk F; Diyachenko G; Zabelina T; Wolschke C; Fehse B; Bacher U; Erttmann R; Kröger N; Zander AR
Biol Blood Marrow Transplant; 2008 Aug; 14(8):913-9. PubMed ID: 18640575
[TBL] [Abstract][Full Text] [Related]
59. Hematopoietic stem cell transplantation for thalassemia.
Elborai Y; Uwumugambi A; Lehmann L
Immunotherapy; 2012 Sep; 4(9):947-56. PubMed ID: 23046238
[TBL] [Abstract][Full Text] [Related]
60. Risk-adapted procedures for HSCT from alternative donor in children with severe aplastic anaemia.
Führer M
Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S97-100. PubMed ID: 18978755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
